Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Return on Equity (2016 - 2025)

Conmed (CNMD) has disclosed Return on Equity for 11 consecutive years, with 0.18% as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Return on Equity fell 51.0% year-over-year to 0.18%, compared with a TTM value of 0.18% through Sep 2021, down 51.0%, and an annual FY2025 reading of 0.05%, down 10.0% over the prior year.
  • Return on Equity was 0.18% for Q3 2021 at Conmed, down from 0.37% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.75% in Q3 2018 and bottomed at 0.18% in Q3 2021.
  • Average Return on Equity over 5 years is 0.66%, with a median of 0.7% recorded in 2017.
  • The sharpest move saw Return on Equity grew 6bps in 2017, then crashed -51bps in 2021.
  • Year by year, Return on Equity stood at 0.75% in 2017, then fell by -5bps to 0.71% in 2018, then rose by 3bps to 0.74% in 2019, then decreased by -10bps to 0.66% in 2020, then crashed by -73bps to 0.18% in 2021.
  • Business Quant data shows Return on Equity for CNMD at 0.18% in Q3 2021, 0.37% in Q2 2021, and 0.48% in Q1 2021.